24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Biomed
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
11:51
Could Prompt Security be SentinelOne’s lifeline as shares slide 35% this year?
11:21
“Combined with AI and classical computing, quantum computing is the most dangerous tool we’ve ever had”
10:51
Women, work, and menopause: Navigating income, expenses, and career transitions
10:31
Harvard professor files $2M claim against insolvent tech founder Moshe Yanai amid $120M debt crisis
More stories
Buzz
Most popular
Daily
Weekly
1
“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals
2
Nice puts Actimize up for sale at a $1.5-2 billion price tag
3
Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program
4
Zafran raises $60 million and doubles valuation as it chooses independence over takeover offers
5
Israeli drone startup Heven hits $1 billion valuation in $100 million round led by IonQ
More news
Biomed
9 stories about Biomed
Fourth Time’s the Charm for Entera Bio IPO
01.07.18
|
Dror Reich
The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each
Entera Bio Gives Nasdaq IPO Another Shot
21.05.18
|
Dror Reich
This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq
Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange
29.04.18
|
Racheli Bindman
Dually listed on Nasdaq and TASE, Opko first submitted a request to delist from the TASE in early April
An Israeli Company Wants to Treat Tourette Syndrome With Cannabis
09.04.18
|
Lilach Baumer
Therapix Biosciences announced the successful completion of phase 2 clinical trial of its cannabinoid-based drug, conducted at Yale University Monday
For the Fourth Time, Entera Bio Tries for Nasdaq IPO
08.01.18
|
Dror Reich
The Jerusalem-based biomed company plans to raise $55 million, with Oppenheimer & Co. as the sole underwriter
Biomed Company Protalix to Lay Off a Fifth of its Workforce
26.11.17
|
Dror Reich
The Israel-based NYSE American-listed company is currently undergoing a streamlining process
Entera Bio Files for Nasdaq IPO
12.11.17
|
Lilach Baumer
The clinical stage company develops treatments mostly for osteoporosis and bone disorders
Collplant Takes a Step Towards 3D Organ Printing
17.10.17
|
Lilach Baumer
The Israel-based company develops collagen-based biological ink for 3D organ printing
IPO Hopeful Entera Bio Moves to Better Position
13.09.17
|
Dror Reich
Clinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism
Previous Articles